Recent Project-related Publications

September 2019:

• Agelopoulos K, Rülander F, Dangelmaier J, Lotts L, Osada N, Metze D, Luger TA, Loser K, Ständer S. Neurokinin 1 receptor antagonists exhibit peripheral effects in prurigo nodularis including reduced ERK1/2 activation. J Eur Acad Dermatol Venereol 2019 in press

• Pereira MP, Zeidler C, Storck M, Agelopoulos K, Philipp-Dormston WG, Zink A, Ständer S. Challenges in Clinical Pruritus Research and Care. Acta Derm Venereol 2019; in press
• Süer A, Soto Rey, I, Storck M, Pereira MP, Agelopoulos K, Ständer S, Dugas M, Bruland P. Standardbasierte vernetzte IT-Infrastruktur zur multizentrischen und multidisziplinären Verwaltung von Forschungsdaten – Integration im Rahmen der DFG-geförderten Forschergruppe „PruSearch. Deutsche Gesellschaft für Medizinische Informatik, Biometrie und Epidemiologie. 64. Jahrestagung der Deutschen Gesellschaft für Medizinische Informatik, Biometrie und Epidemiologie e.V. (GMDS). Dortmund, 08.-11.09.2019. Düsseldorf: German Medical Science GMS Publishing House; 2019. DocAbstr. 179 . doi: 10.3205/19gmds173
  

July 2019:

• Mueller SM, Schmid Y, Navarini A, Manjaly Thomas ZR, Pfleiderer B, Kraehenbuehl S. Sex differences in the pharmacology of itch therapies - a narrative review Curr Opin Pharmacol, 2019, 46:122–142. https://doi.org/10.1016/j.coph.2019.05.008
• Pereira MP, Agelopoulos K, Köllner J, Neufang G, Schmelz M, Ständer S. Selective nerve fiber activation in patients with chronic generalized pruritus: hint for central sensitization? Acta Derm Venereol 2019 https://www.medicaljournals.se/acta/content/abstract/10.2340/00015555-3261
• Pogatzki-Zahn EM, Pereira MP, Cremer A, Zeidler C, Dreyer T, Riepe C, Wempe C, Lotts T, Segelcke D, Ringkamp M, Kremer AE, Agelopoulos K, Ständer S. Peripheral sensitisation and loss of descending inhibition is a hallmark of chronic pruritus. J Invest Dermatol 2019, in press https://www.sciencedirect.com/science/article/abs/pii/S0022202X19318512?via%3Dihub

June 2019:

• Role of the Pruritic Cytokine IL-31 in Autoimmune Skin Diseases. Gibbs BF, Patsinakidis N, Raap U. Front Immunol. 2019 Jun 21;10:1383. doi: 10.3389/fimmu.2019.01383. eCollection 2019. Review.
  

May 2019:

• Ständer S. How to define chronic pruritus – symptom or disease? Exp Dermatol 2019, https://onlinelibrary.wiley.com/doi/full/10.1111/exd.13953
• Steinhoff M, Oaklander AL, Szabó IL, Ständer S, Schmelz M. Neuropathic itch. Pain 2019;160 Suppl 1:S11-S16 https://insights.ovid.com/pubmed?pmid=31008844
• Robering JW, Gebhardt L, Wolf K, Kühn H, Kremer AE*, Fischer MJM*. Lysophosphatidic acid activates satellite glia cells and Schwann cells. Glia. 2019 May;67(5):999-1012. *contributed equally (IF2017: 6,2)
  

March 2019:

• Tsianakas A, Nippe N, Hamper CM, Cordes AF, Zeidler C, Schmelz M, Ständer S. Exploratory Study of Intracutaneous Histamine Stimulation in Patient Populations with Chronic Pruritus. Acta Derm Venereol. 2019; 99: 291-297. doi: 10.2340/00015555-3078. https://www.medicaljournals.se/acta/content/abstract/10.2340/00015555-3078
  

December 2018:

• Pereira MP, Mittal A, Ständer S. Current treatment strategies in refractory chronic pruritus. Curr Opin Pharmacol 2018; 46: 1-6 https://www.sciencedirect.com/science/article/pii/S1471489218301280?via%3Dihub